PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
67.47
+0.72 (1.08%)
At close: Jul 19, 2024, 4:00 PM
67.45
-0.02 (-0.03%)
Pre-market: Jul 22, 2024, 7:39 AM EDT
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 62.6, with a low estimate of 37 and a high estimate of 79. The average target predicts a decrease of -7.22% from the current stock price of 67.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRCT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 5 | 5 | 5 | 4 | 4 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 6 | 6 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Strong Buy Maintains $72 → $79 | Strong Buy | Maintains | $72 → $79 | +17.09% | Jul 16, 2024 |
TD Cowen | TD Cowen | Strong Buy Maintains $65 → $75 | Strong Buy | Maintains | $65 → $75 | +11.16% | May 6, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $67 → $75 | Buy | Maintains | $67 → $75 | +11.16% | May 6, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $63 → $72 | Strong Buy | Maintains | $63 → $72 | +6.71% | May 2, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $55 → $58 | Strong Buy | Maintains | $55 → $58 | -14.04% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
218.01M
from 136.19M
Increased by 60.08%
Revenue Next Year
306.42M
from 218.01M
Increased by 40.55%
EPS This Year
-1.97
from -2.24
EPS Next Year
-1.52
from -1.97
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 225.4M | 328.7M | 440.5M | 506.7M | 595.4M |
Avg | 218.0M | 306.4M | 403.2M | 484.9M | 569.2M |
Low | 208.9M | 271.4M | 336.7M | 458.8M | 538.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 65.5% | 50.7% | 43.8% | 25.7% | 22.8% |
Avg | 60.1% | 40.6% | 31.6% | 20.3% | 17.4% |
Low | 53.4% | 24.5% | 9.9% | 13.8% | 11.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.95 | -1.22 | -0.44 | -0.09 | 0.47 |
Avg | -1.97 | -1.52 | -0.87 | -0.20 | 0.28 |
Low | -1.95 | -1.66 | -1.14 | -0.30 | 0.10 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.